When is it time to walk away from the potential acquisition of a health care company that is under government investigation? That’s the important question confronting many buyers in health care transactions. In an article published by the Deal Pipeline entitled “Pulling the Plug?” author Karen Lovitch, leader of the firm’s Health Law Practice, provides some guidance on how to distinguish between a deal killer and a point for further negotiation.